Polygonatum sibiricum liquid fermentation product and preparation method and application thereof
By using brewer's yeast SY to liquid ferment Polygonatum and then freeze-drying it for extraction, the problem of time-consuming and labor-intensive processing of Polygonatum was solved, achieving significant effects in lowering blood lipids and blood sugar, as well as antioxidant benefits.
Patent Information
- Application Number
- CN202410772965.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-14
- Publication Date
- 2024-11-19
AI Technical Summary
Existing processing methods for Polygonatum are time-consuming and labor-intensive, and traditional methods have failed to effectively improve its lipid-lowering and blood sugar-lowering effects.
Polygonatum was fermented in liquid form using Saccharomyces SY, then freeze-dried, and subsequently extracted with water or ethanol to prepare the liquid fermented product of Polygonatum.
It significantly improved the α-glucosidase inhibition rate and pancreatic lipase inhibition rate of Polygonatum sibiricum liquid fermentation product, exhibiting excellent lipid and blood glucose improvement activities and antioxidant capacity.
Smart Images

Figure BDA0004897161570000071 
Figure BDA0004897161570000081 
Figure BDA0004897161570000082
Abstract
Description
Technical Field
[0001] The present application relates to the field of plant fermentation, and in particular to a liquid fermentation product of polygonatum and a preparation method and application thereof. Background Art
[0002] Polygonatum sibiricum, also known as tiger ginger, is the dried rhizome of the plant of the genus Polygonatum in the Liliaceae family. It is a traditional Chinese herbal medicine with both medicinal and edible properties. Polygonatum sibiricum was first recorded in the "Famous Doctors' Records" and was rated as the highest-level herbal medicine. According to existing research, Polygonatum sibiricum has the effects of improving immunity, anti-aging, anti-diabetes, anti-fatigue, anti-cancer, and anti-heart disease, so its active substances have received widespread attention. Polygonatum sibiricum contains polysaccharides, steroidal saponins, triterpenes, flavonoids, phytosterols, etc., all of which show biological activity.
[0003] Raw Polygonatum is rich in mucus and produces a strong numbing taste when eaten raw, so Polygonatum needs to be processed before it can be used as medicine or food. The traditional processing method of Polygonatum is "nine steaming and nine drying", which is time-consuming and laborious. Fermentation is one of the most important methods in the processing of traditional Chinese medicinal materials. It can reduce the toxicity of traditional Chinese medicine and improve its efficacy. Summary of the invention
[0004] In view of this, the purpose of the present application is to provide a liquid fermented product of Polygonatum sibiricum and a preparation method thereof, so that it can significantly improve the effects of lowering blood lipids and blood sugar at the same time;
[0005] Another object of the present application is to provide an application of the above-mentioned liquid fermentation product of Polygonatum sibiricum in the preparation of products for improving blood lipids and blood sugar.
[0006] In order to solve the above technical problems / achieve the above objectives or at least partially solve the above technical problems / achieve the above objectives, as a first aspect of the present application, a method for preparing a liquid fermented product of polygonatum is provided, comprising:
[0007] The brewer's yeast SY is inoculated into a culture medium containing polygonatum, fermented within a fermentation temperature range suitable for the brewer's yeast SY, and freeze-dried after fermentation to obtain the polygonatum liquid fermentation product.
[0008] Optionally, the culture medium containing Polygonatum sibiricum is a mixture of Polygonatum sibiricum and water.
[0009] Optionally, the suitable fermentation temperature range of the Saccharomyces cerevisiae SY is 30±2°C.
[0010] Further optionally, the preparation method further comprises: after freeze-drying, extracting the freeze-dried solid using water as an extraction solvent; or further comprises: after freeze-drying, extracting the freeze-dried solid using ethanol as an extraction solvent.
[0011] As a second aspect of the present application, provided is a liquid fermentation product of Polygonatum sibiricum prepared by the preparation method described in the present application.
[0012] As a third aspect of the present application, provided is the use of the liquid fermented product of polygonatum described in the present application in the preparation of a product having the efficacy of improving blood lipids and / or blood sugar.
[0013] As a fourth aspect of the present application, a product having the efficacy of improving blood lipids and blood sugar is provided, with the liquid fermentation product of Polygonatum sibiricum described in the present application as an effective ingredient.
[0014] As a fifth aspect of the present application, provided is the use of Saccharomyces cerevisiae SY in preparing a fermented product of Polygonatum cyrtonema or in the fermentation of Polygonatum cyrtonema.
[0015] The present application uses suitable brewer's yeast SY to carry out liquid fermentation of polygonatum, and the fermented product prepared has significantly improved α-glucosidase inhibition rate and pancreatic lipase inhibition rate compared with raw polygonatum and fermented products of other microbial strains, showing extremely excellent activity in improving blood lipids and blood sugar. The present application not only provides an effective, time-saving and energy-saving method for preparing polygonatum, but also provides a broad basis for the further application of polygonatum. DETAILED DESCRIPTION
[0016] The present application discloses a liquid fermentation product of polygonatum and its preparation method and application. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve it. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all deemed to be included in this application. The products, applications and preparation methods of this application have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods described herein without departing from the content, spirit and scope of this application to implement and apply the technology of this application.
[0017] Saccharomyces cerevisiae SY is a special yeast for wine and fruit wine produced by Angel Yeast, which can be purchased through commercial channels; its conventional use is mainly to ferment white wine. At present, the research on the lipid-lowering effect of Saccharomyces cerevisiae is mainly focused on the transformation of Saccharomyces cerevisiae by exogenous gene recombination.
[0018] This application uses Polygonatum sibiricum as raw material and adopts liquid and solid fermentation methods to study the effects of microbial strains and fermentation methods on the content of Polygonatum sibiricum polysaccharides and its antioxidant, hypoglycemic and hypolipidemic activities. It is unexpectedly found that brewer's yeast SY has better effects than other strains in improving the lipid-lowering and blood sugar-lowering effects of liquid fermentation products of Polygonatum sibiricum.
[0019] In the first aspect of the present application, a method for preparing a liquid fermented product of Polygonatum sibiricum is provided, comprising:
[0020] The brewer's yeast SY is inoculated into a culture medium containing polygonatum, fermented within a fermentation temperature range suitable for the brewer's yeast SY, and freeze-dried after fermentation to obtain the polygonatum liquid fermentation product.
[0021] In certain embodiments of the present application, the SY inoculation of Saccharomyces cerevisiae also includes an activation step, wherein the SY powder of Saccharomyces cerevisiae is taken and added to a sterilized glucose solution for activation. 600nm At least 1.7, the colony count must be at least 4×10 9 CFU / mL can be used for inoculation. Generally, the inoculation volume is about 2%.
[0022] In certain embodiments of the present application, the culture medium containing Polygonatum sibiricum is a mixture of Polygonatum sibiricum and water, and the solid-to-liquid ratio of Polygonatum sibiricum to water is 1-3 g: 5-15 mL.
[0023] In some embodiments of the present application, the suitable fermentation temperature range of the brewer's yeast SY is 30±2°C, and the fermentation time is 48-96h. In some other embodiments of the present application, the brewer's yeast SY is inoculated and placed in a constant temperature shaker at 140r / min and 30°C for fermentation for 72h.
[0024] In certain embodiments of the present application, the preparation method further comprises: after freeze-drying, extracting the freeze-dried solid with water as an extraction solvent, and the extraction temperature can be selected as 70±10°C; more specifically, leaching the freeze-dried solid with water as an extraction solvent, and then deproteinizing the collected supernatant, collecting the supernatant again and performing alcohol precipitation, collecting the precipitate, and the precipitate can be re-dissolved in water as needed to form a solution of a certain concentration; wherein, the deproteinization can be carried out using trichloroacetic acid.
[0025] In certain embodiments of the present application, the preparation method further includes: after freeze-drying, extracting the freeze-dried solid with ethanol as an extraction solvent; more specifically, soaking the freeze-dried solid with ethanol, assisted by ultrasonic extraction, and one or more extractions can be performed as needed, and the filtrates are combined.
[0026] In a second aspect of the present application, a liquid fermentation product of Polygonatum sibiricum prepared by the preparation method described in the present application is provided.
[0027] In the third aspect of the present application, the present application tested the hypoglycemic and hypolipidemic activities after extracting the freeze-dried solid with water as solvent. The results showed that the α-glucosidase inhibition rate and pancreatic lipase inhibition rate were significantly improved, which was not only better than acarbose and orlistat, but also showed extremely excellent activity in improving blood lipids and blood sugar relative to other microbial strains. Based on these technical effects, the application of the liquid fermentation product of Polygonatum sibiricum described in the present application in the preparation of products with the effect of improving blood lipids and / or blood sugar is provided, especially the extract that was subjected to water extraction and alcohol precipitation after freeze-drying.
[0028] The present application also tested the antioxidant activity of the freeze-dried solid after extraction with ethanol as solvent, and the results showed that the DPPH free radical scavenging rate, hydroxyl free radical scavenging rate, total reducing power, and superoxide anion free radical scavenging rate all maintained a high level, which was significantly superior to ascorbic acid. Based on these technical effects, the application of the liquid fermentation product of Polygonatum sibiricum described in the present application in the preparation of products with antioxidant effects is provided, especially the extract extracted with ethanol after freeze-drying.
[0029] In the fourth aspect of the present application, a product having the effect of improving blood lipids and blood sugar is provided, with the liquid fermentation product of polygonatum described in the present application as an effective ingredient. In addition, the product also has an antioxidant effect, and can also be used in combination with other suitable excipients or active ingredients.
[0030] In the fifth aspect of the present application, in view of the advantages of Saccharomyces cerevisiae SY compared with other microbial strains, the present application provides the use of Saccharomyces cerevisiae SY in preparing Polygonatum cyrtonema fermentation or in Polygonatum cyrtonema fermentation. Among them, as a preferred choice, the fermentation or fermentation is a liquid fermentation or liquid fermentation.
[0031] In each group of comparative experiments provided in this application, unless otherwise specified, other experimental conditions, materials, etc. are kept consistent except for the differences noted in each group, so as to provide comparability. In addition, the polygonatum sibiricum used in this application is the rhizome of the Chinese medicinal material polygonatum sibiricum, which is usually crushed into powder for use, and all materials can be purchased through commercial channels.
[0032] The following is a further description of a liquid fermentation product of Polygonatum sibiricum provided in the present application and its preparation method and application.
[0033] Embodiment 1:
[0034] (1) Strain activation and culture medium preparation
[0035] Take 2 mL of SY powder in EP tube, add it to 100 mL of sterilized glucose solution (100 mg / mL), activate it in a water bath at 28°C for 30 min, and measure the OD before inoculation. 600nm Value and viable count, OD 600nm At least 1.7, the colony count must be at least 4×10 9 CFU / mL can be used for inoculation.
[0036] After drying, the polygonatum was crushed in a Chinese herbal medicine grinder and passed through a 60-mesh screen. 10 g of polygonatum powder was weighed and placed in a 500 mL conical flask. 50 mL of sterile water (viscous) was added to the flask at a solid-liquid ratio of 1:5 (w:v). The mixture was sterilized at 121°C for 15 min.
[0037] (2) Liquid fermentation
[0038] In the clean operating table, inoculate 2% activated brewer's yeast SY, place in a constant temperature shaker at 140r / min, 30°C for 72h. After the fermentation is completed, freeze-dry the fermentation sample, grind it in a mortar, and store it at 4°C for later use.
[0039] (3) Extraction and purification of Polygonatum sibiricum polysaccharide
[0040] Weigh 1g of liquid fermented freeze-dried powder of Polygonatum sibiricum, add pure water at a solid-liquid ratio of 1:20 (w / v), and extract in a constant temperature water bath at 70°C for 2h. Collect the supernatant by centrifugation and discard the residue. Mix with 15% trichloroacetic acid reagent at a ratio of 1:4 (v / v), let stand at 4°C for 4h for deproteinization, centrifuge at 7500r / min for 10min, and aspirate the supernatant. Add 4 times the volume of the supernatant to the supernatant with anhydrous ethanol and precipitate overnight. Centrifuge at 7500r / min for 10min, collect the precipitate, and add 20mL of pure water to reconstitute.
[0041] (4) Preparation of ethanol extract
[0042] Weigh 1 g of liquid fermented freeze-dried powder of Polygonatum sibiricum, add the sample into 70% ethanol solution at a solid-liquid ratio of 1:20 (w / v), soak for 2 hours, ultrasonicate for 30 minutes at a power of 500 W, a frequency of 40 kHz, and a temperature of 40°C, filter, collect the filtrate, repeat the extraction twice, combine the filtrates, and obtain the sample to be tested.
[0043] Comparative Example:
[0044] (1) Strain activation and culture medium preparation
[0045] Activation of Lactobacillus plantarum Picp-2: Lactobacillus plantarum Picp-2 was deposited in China Center for Type Culture Collection, numbered CCTCC No: M 20191045; the deposited strain (2 mL EP tube) was taken out from a -60 ° C refrigerator, inoculated into 100 mL MRS medium, and continuously subcultured at 37 ° C for 12 h per generation. The F3 generation strain was inoculated, and the OD was measured before inoculation. 600nm Value and viable count, OD 600nm The number of colonies must be at least 1.50 and at least 2 × 10 9 CFU / mL can be used for inoculation.
[0046] Activation of Bacillus natto YY-1: Bacillus natto YY-1 was purchased from China Center for Type Culture Collection, numbered CCTCC No: CB 20081702; the strain was taken out of the -60°C refrigerator (2 mL EP tube), inoculated into 100 mL LB medium, and activated by continuous subculture at 37°C, with each generation cultured for 12 h. The F3 generation strain was taken for inoculation, and the OD was measured before inoculation. 600nmValue and viable count, OD 600nm The value should be at least 1.20, and the colony count should be at least 2×10 9 CFU / mL can be used for inoculation.
[0047] Preparation of spore suspension of Ganoderma lucidum: Ganoderma lucidum was deposited in China Center for Type Culture Collection, with the number of CCTCC No: KF 2008392. The preserved mycelium of Ganoderma lucidum was inoculated on MEA solid medium, cultured at 28°C for 7-9 days, and the mycelium with good growth was scraped and added to 100 mL MEA liquid medium, incubated at 28°C, 120r / min for 3 days, and then set aside.
[0048] Preparation of Aspergillus niger spore suspension: Aspergillus niger was deposited in China Center for Type Culture Collection, numbered CCTCC No: AF 200036. Aspergillus niger was inoculated on potato dextrose agar (PDA) medium, cultured at 30°C for 7-9 days, and the well-growing spores were scraped and added to 100 mL of sterile water, shaken at 120 r / min for 30 minutes, and set aside.
[0049] The culture medium was prepared as in Example 1.
[0050] (2) Liquid fermentation
[0051] In the super-clean operating table, 10% activated Lactobacillus plantarum Picp-2 and 10% natto Bacillus subtilis YY-1 were inoculated respectively, and the viable count of each strain inoculated was consistent with the viable count of yeast SY inoculated in Example 1, and an equal amount of sterile water (raw polygonatum group) was added to the control group. The control group, Picp-2, and YY-1 fermentation groups were placed in a constant temperature shaking table at 140r / min and fermented at 37°C for 72h. After the fermentation was completed, the fermented sample was freeze-dried, ground and pulverized in a mortar, and stored at 4°C for standby use.
[0052] (3) Solid-state fermentation
[0053] After drying, polygonatum is put into a Chinese medicinal material grinder and crushed, and passed through a 60-mesh sieve. Polygonatum powder is sterilized at 121°C for 20min. In a sterile operating table, 15g of sterilized polygonatum powder is weighed in a culture dish, 15mL of sterile water (final water content 65% to 70%) is added, and then 10% of Chinese red ganoderma liquid and Aspergillus niger spore suspension are respectively accessed. The number of viable bacteria inoculated by each strain is consistent with the number of viable bacteria inoculated by yeast SY in Example 1, and the mixture is sealed after mixing, and placed in a 28°C constant temperature incubator for cultivation. Sterilization is not inoculated with an equal amount of sterile water instead of spore suspension. Fermented polygonatum is placed in a freeze dryer and dried, and after constant weight, it is ground and crushed with a mortar to obtain a polygonatum solid fermentation product, which is stored at 4°C for standby use.
[0054] (3) Extraction and purification of Polygonatum sibiricum polysaccharide
[0055] Refer to Example 1.
[0056] (4) Preparation of ethanol extract
[0057] Refer to Example 1.
[0058] Experimental example:
[0059] (1) DPPH free radical scavenging rate:
[0060] Use a pipette to draw 1mL of extract into a 2mL EP tube, then add 1mL of 0.2mmol / L DPPH. Replace DPPH with an equal amount of anhydrous ethanol in the control group, replace the extract with an equal amount of anhydrous ethanol for sterilization without inoculation, shake and mix, and let it react for 30 minutes in the dark. Pipette 200μL of reaction solution into the ELISA plate, put it into the ELISA reader, and measure the OD517 nm value at a wavelength of 517nm. Use vitamin C as a positive control. Calculate the clearance rate according to the following formula:
[0061]
[0062] Where: R1: DPPH free radical scavenging rate, %; A: experimental group OD517 nm; B: control group OD517 nm; C: sterilization without inoculation OD517 nm
[0063] (2) Hydroxyl free radical scavenging rate:
[0064] Use a pipette to draw 2mL of the extract into a 10mL EP tube, then add 2mL of 6mmol / LFeSO4 and 6mmol / L H2O2 respectively, shake and mix, let stand for 10min, sterilize and replace the extract with an equal amount of pure water without inoculation; then add 2mL of 6mmol / L salicylic acid solution, shake and mix, let stand for 30min. After the reaction is completed, draw 200μL of the reaction solution into the ELISA plate, put it into the ELISA reader, and measure the OD510 nm value at a wavelength of 510nm. Vitamin C is used as a positive control. Calculate the clearance rate according to the following formula:
[0065]
[0066] Where: R2: hydroxyl radical scavenging rate, %; A: OD510 nm of the experimental group; B: OD510 nm of the control group
[0067] (3) Total reducing power:
[0068] Pipette 1mL of extract into a 10mL EP tube, add 2.5mL of 0.2mol / L PBS solution and 1% K3[Fe(CN)6] solution respectively, shake and mix, place in a water bath, react at 50℃ for 20min, add 2.5mL10%C2HCl3O2 solution, quickly pipette the supernatant and pure water in equal proportions to 5mL, finally add 0.5mL 0.1% FeCl3 solution, shake and mix, and let react for 10min. Pipette 200μL of reaction solution into the ELISA plate, put it into the ELISA reader, and measure the OD700 nm value at an absorbance wavelength of 700nm. The total reducing power of the sample is positively correlated with the OD value.
[0069] (4) ABTS free radical scavenging rate:
[0070] Take 25mL of 7.4mmol / L ABTS and 2.6mmol / L K2S2O8, mix them, and let them stand at room temperature in the dark for 12 hours. Dilute the mixture with 95% ethanol until its absorbance at 735nm is 0.68-0.72. Pipette 0.2mL of the sample solution into a 2ml EP tube, replace the sample solution to be tested with 95% ethanol as a blank group, make up to 1mL with the diluted reagent, and let it stand for 6 minutes. Pipette 200μL of the reaction solution and measure the absorbance at a wavelength of 734nm. Calculate the clearance rate according to the following formula
[0071]
[0072] Where: R3: ABTS free radical scavenging rate; A: absorbance of the experimental group; B: absorbance of the control group;
[0073] (5) Determination of hypoglycemic and hypolipidemic activity
[0074] α-Glucosidase inhibition test
[0075] Pipette 0.2mL sample, add 1mL α-glucosidase solution (0.1U / mL), and react at 37℃ for 10min. Add 0.5mL 5mmol / mL PNPG (4-nitrophenyl-β-D-pyranoglucoside) solution, and react at 37℃ for 10min. Finally, add 1mL 0.1mol / L Na2CO3 solution to terminate the reaction, and measure the absorbance at 405nm. The positive control is 100μg / mL acarbose solution.
[0076]
[0077] Where: R4: α-glucosidase inhibition rate; A: absorbance of the experimental group; B: absorbance of the experimental background group (pure water replaces the enzyme solution); C: absorbance of sterilization without inoculation (pure water replaces the sample); D: absorbance of the blank background group (pure water replaces the sample and enzyme solution);
[0078] Pancreatic lipase inhibition test
[0079] 500 μL of sample, pancreatic lipase (1.2 U / mL), and PBS (pH = 7.4) were taken respectively, mixed and reacted at 37°C for 10 minutes. 500 μL of P-NPB (4-Nitrophenyl butyrate) solution (11.2 mol / L) was added, mixed and reacted at 37°C for 20 minutes. After the reaction, the absorbance was quickly measured at 405 nm. The positive control was 100 μg / mL orlistat solution.
[0080]
[0081] Where: R5: pancreatic lipase inhibition rate; A: absorbance of the experimental group; B: absorbance of the experimental background group (pure water replaces enzyme solution); C: absorbance of sterilization without inoculation (pure water replaces sample); D: absorbance of the blank background group (pure water replaces sample and enzyme solution);
[0082] (6) Determination of Polygonatum sibiricum Polysaccharide Content
[0083] The polysaccharide content was determined according to the phenol-sulfuric acid method (GB / T 15672-2009): 1 mL of polysaccharide solution was taken into a 15 mL stoppered test tube. 1 mL of 5% phenol was added to each test tube, and 5 mL of concentrated sulfuric acid was added along the tube wall. The reaction system was quickly shaken to mix evenly. The test tube was placed in boiling water for 20 minutes, cooled to room temperature in running water for 5 minutes, and the OD value of the reaction system was measured at 490 nm.
[0084] The polysaccharide standard curve was drawn using glucose as the standard. A 0.33 mg / mL glucose solution was prepared. 0, 0.1, 0.2, 0.4, 0.6, and 0.8 mL of glucose solution were drawn, respectively, and the volume was made up to 1 mL with pure water. The OD490 nm was measured according to the above test method, with the concentration as the horizontal axis and the OD 490nm Draw a standard curve for the ordinate (y = 5.6812x + 0.0618, R 2 =0.9997).
[0085] (7) Results
[0086] Table 1 Total sugar content of Polygonatum cyrtonema polysaccharide extracts with different treatments
[0087]
[0088] As can be seen from Table 1, the total sugar content of Saccharomyces cerevisiae SY after liquid fermentation is in the middle among all microbial groups, the total sugar levels of Lactobacillus plantarum Picp-2 and Bacillus natto YY-1 are relatively high, and the total sugar levels of G. sinensis and Aspergillus niger are relatively poor, which indicates that different strains and different fermentation methods will affect the total sugar content in the fermentation product.
[0089] Table 2 DPPH free radical scavenging rate of ethanol extracts under different treatments (stock solution)
[0090]
[0091] Table 3 DPPH free radical scavenging rate of ethanol extracts under different treatments (10-fold dilution)
[0092]
[0093]
[0094] Table 4 ABTS free radical scavenging rate of ethanol extracts with different treatments (original solution)
[0095]
[0096] Table 5 ABTS free radical scavenging rate of ethanol extracts under different treatments (10-fold dilution)
[0097]
[0098] Table 6 Hydroxyl radical scavenging rate of ethanol extracts under different treatments (stock solution)
[0099]
[0100]
[0101] Table 7 Hydroxyl radical scavenging rate of ethanol extracts in different treatments (10-fold dilution)
[0102]
[0103] From the results of different antioxidant experiments in Tables 2 to 7, it can be seen that in the free radical scavenging experiments of the original solution, there is little difference between the strain groups and the hemic acid resistant group; but after 10-fold dilution, the free radical scavenging rate of each strain group is generally higher than that of the hemic acid resistant group, showing better antioxidant capacity, among which the comprehensive ability of scavenging various free radicals of Saccharomyces cerevisiae SY is better.
[0104] Table 8 Total reducing power of ethanol extracts under different treatments
[0105]
[0106]
[0107] It can be seen from Table 8 that in terms of total reducing power, the ethanol extract after fermentation of Saccharomyces cerevisiae SY has the highest total reducing power among all strain groups, which is close to the total reducing power of anti-hemolytic acid. Combining the results of Tables 2 to 7, it can be seen that the fermentation products of Saccharomyces cerevisiae SY have strong antioxidant capacity.
[0108] Table 9 α-glucosidase inhibition rate of polysaccharide extracts treated with different methods (5-fold dilution)
[0109]
[0110] As shown in Table 9, among the single strains, the α-glucosidase inhibition rate of the polysaccharide extract after fermentation with Saccharomyces cerevisiae SY was the highest, and the inhibition rate was improved to a certain extent after the combined fermentation of Lactobacillus plantarum Picp-2 and Saccharomyces cerevisiae SY.
[0111] Table 10 Pancreatic lipase inhibition rate of polysaccharide extracts treated with different methods (5-fold dilution)
[0112]
[0113] It can be seen from Table 10 that among the single strains, the pancreatic lipase inhibition rate of the polysaccharide extract after fermentation of Saccharomyces cerevisiae SY is the highest, and is significantly higher than the positive control group-orlistat; however, the pancreatic lipase inhibition rate decreases after the combined fermentation of Lactobacillus plantarum Picp-2 and Saccharomyces cerevisiae SY. It is speculated that the two strains interfere with each other during the combined fermentation process. Combined with the experimental results in Table 9, Saccharomyces cerevisiae SY is the best fermentation strain.
[0114] The above is only a preferred implementation of the present application. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present application. These improvements and modifications should also be regarded as the scope of protection of the present application.
Claims
1. A method for preparing liquid fermented product of polygonatum, characterized in that: include: The brewer's yeast SY is inoculated into a culture medium containing polygonatum, fermented within a fermentation temperature range suitable for the brewer's yeast SY, and freeze-dried after fermentation to obtain the polygonatum liquid fermentation product.
2. The preparation method according to claim 1, characterized in that: The culture medium containing polygonatum is a mixture of polygonatum and water.
3. The preparation method according to claim 1, characterized in that: The suitable fermentation temperature range of the Saccharomyces cerevisiae SY is 30±2°C.
4. The preparation method according to any one of claims 1 to 3, characterized in that: Also includes: After freeze-drying, the freeze-dried solid was extracted with water as the extraction solvent.
5. The preparation method according to any one of claims 1 to 3, characterized in that: Also includes: After freeze-drying, the freeze-dried solid was extracted with ethanol as the extraction solvent.
6. Liquid fermented product of polygonatum sibiricum prepared by the preparation method according to any one of claims 1 to 5.
7. Use of the liquid fermented product of polygonatum sibiricum according to claim 6 in preparing a product having the efficacy of improving blood lipids and / or blood sugar.
8. A product having the effect of improving blood lipids and blood sugar, characterized in that: The liquid fermented product of polygonatum sibiricum as claimed in claim 6 is used as the effective ingredient.
9. Application of Saccharomyces cerevisiae SY in the preparation of Polygonatum cyrtonema fermentation products or in Polygonatum cyrtonema fermentation.
Citation Information
Cited By
Preparation process of microcapsule composition containing adenosine and application of microcapsule composition in preparation of anti-aging effect product
CN121845964A
